The month of December 2024 saw a variety of biotech deals take place to advance therapies across different stages in ...

Novo Nordisk's shares plummeted due to disappointing trial results for CagriSema, with patients achieving only 22.7% weight ...

I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

The new pan-European group of 73 regulators, companies and trial sites is backed by €66.8m in funding with a six-year goal.

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 performance.

Novo Nordisk has announced plans to move its ziltivekimab into phase 3 clinical development in atherosclerosis with chronic kidney disease after a mid-stage trial met its main goal.

Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is ...

NC State researchers found that blueberry powdery mildew has spread globally in two strains, costing the industry up to $530 ...

Jonas Vingegaard is talking up the Tour de France battle between him and Tadej Pogačar and he will ride two Grand Tours this ...

Instead, it allowed for a blood sample to be inoculated with a radioactive form of thyroid hormone. Ausria, a radioimmunoassay test to detect serum hepatitis, was launched in 1972 and marked the ...